<- Go Home
Diabetes Diagnostics, Inc.
Diabetes Diagnostics, Inc. develops, manufactures, and markets diabetes self-management products in the United States and Europe. It offers electrochemical blood glucose monitoring systems, which include meters and associated test strips. These systems are used by people with diabetes to determine their blood glucose levels. The company provides alternative blood glucose test strips for use in various meters; and diagnostic test products, including genetic assays, immunoassays, and rapid and confirmatory tests. It also offers self-diagnostic test products for women's health and diabetes management, as well as nutritional supplements to women. In addition, the company sells ancillary diabetes supplies, such as syringes, lancets, glucose tablets, and specialty skin creams. It has manufacturing, and research and development facilities in Inverness, Scotland; St. Paul, Minnesota; Galway, Ireland; and Yavne, Israel. The company was formerly known as Selfcare, Inc. It changed its name to Inverness Medical Technology, Inc. in 2000 and then to Diabetes Diagnostics, Inc. in 2002. The company was founded in 1992 and is based in Waltham, Massachusetts. Diabetes Diagnostics, Inc. operates as a subsidiary of Johnson & Johnson.
Market Cap
$1.3B
Volume
247.3K
Cash and Equivalents
$19.6M
EBITDA
$24.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$77.5M
Profit Margin
34.43%
52 Week High
$41.00
52 Week Low
$16.87
Dividend
N/A
Price / Book Value
8.05
Price / Earnings
-25.40
Price / Tangible Book Value
24.58
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$13.9M
Return on Equity
46.65%
Return on Assets
4.86
Cash and Short Term Investments
$19.6M
Debt
$20.4M
Equity
$163.8M
Revenue
$225.0M
Unlevered FCF
-$19.7M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium